Cargando…
Intradermal versus intramuscular COVID-19 vaccination aiming at protection for delta variant: cost utility analysis
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10043819/ https://www.ncbi.nlm.nih.gov/pubmed/36722559 http://dx.doi.org/10.4103/ijp.ijp_271_22 |
_version_ | 1784913234750341120 |
---|---|
author | Mungmunpuntipantip, Rujittika Wiwanitkit, Viroj |
author_facet | Mungmunpuntipantip, Rujittika Wiwanitkit, Viroj |
author_sort | Mungmunpuntipantip, Rujittika |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10043819 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-100438192023-03-29 Intradermal versus intramuscular COVID-19 vaccination aiming at protection for delta variant: cost utility analysis Mungmunpuntipantip, Rujittika Wiwanitkit, Viroj Indian J Pharmacol Letter to the Editor Wolters Kluwer - Medknow 2022 2023-01-31 /pmc/articles/PMC10043819/ /pubmed/36722559 http://dx.doi.org/10.4103/ijp.ijp_271_22 Text en Copyright: © 2023 Indian Journal of Pharmacology https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Letter to the Editor Mungmunpuntipantip, Rujittika Wiwanitkit, Viroj Intradermal versus intramuscular COVID-19 vaccination aiming at protection for delta variant: cost utility analysis |
title | Intradermal versus intramuscular COVID-19 vaccination aiming at protection for delta variant: cost utility analysis |
title_full | Intradermal versus intramuscular COVID-19 vaccination aiming at protection for delta variant: cost utility analysis |
title_fullStr | Intradermal versus intramuscular COVID-19 vaccination aiming at protection for delta variant: cost utility analysis |
title_full_unstemmed | Intradermal versus intramuscular COVID-19 vaccination aiming at protection for delta variant: cost utility analysis |
title_short | Intradermal versus intramuscular COVID-19 vaccination aiming at protection for delta variant: cost utility analysis |
title_sort | intradermal versus intramuscular covid-19 vaccination aiming at protection for delta variant: cost utility analysis |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10043819/ https://www.ncbi.nlm.nih.gov/pubmed/36722559 http://dx.doi.org/10.4103/ijp.ijp_271_22 |
work_keys_str_mv | AT mungmunpuntipantiprujittika intradermalversusintramuscularcovid19vaccinationaimingatprotectionfordeltavariantcostutilityanalysis AT wiwanitkitviroj intradermalversusintramuscularcovid19vaccinationaimingatprotectionfordeltavariantcostutilityanalysis |